well designed controlled studies are underway to establish the efficacy of acyclovir in herpes simplex encephalitis and cytomegalovirus infections in immunocompromised patients , infections due to epstein-barr virus , and neonatal herpesvirus infections .
C0010823
cytomegalovirus infections
C0019372
herpesvirus infections